Cargando…
Core decompression and biotechnologies in the treatment of avascular necrosis of the femoral head
Avascular necrosis (AVN) of the femoral head (FH) causes 5% to 12% of total hip arthroplasties (THA). It especially affects active male adults between the third and fifth decades of life. The exact worldwide incidence is unknown. There are only few data related to each country, but most of it relate...
Autores principales: | Calori, Giorgio Maria, Mazza, Emilio, Colombo, Alessandra, Mazzola, Simone, Colombo, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Editorial Society of Bone and Joint Surgery
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367599/ https://www.ncbi.nlm.nih.gov/pubmed/28461967 http://dx.doi.org/10.1302/2058-5241.2.150006 |
Ejemplares similares
-
Avascular femoral head necrosis in young gymnasts: a pursuit of aetiology and management
por: Blümel, Stefan, et al.
Publicado: (2022) -
Femoral head wedge resection for the treatment of avascular necrosis of the femoral head after pediatric femoral neck fracture: a case report
por: Kim, Ha Yong, et al.
Publicado: (2018) -
Interobserver and Intraobserver Reliability in the Salter Classification of Avascular Necrosis of the Femoral Head in Developmental Dysplasia of the Hip
por: Schaeffer, Emily K., et al.
Publicado: (2022) -
The Results of Core Decompression Treatment in Avascular Necrosis of the Femoral Head
por: Talmaç, Mehmet Ali, et al.
Publicado: (2018) -
Modifications to advanced Core decompression for treatment of Avascular necrosis of the femoral head
por: Landgraeber, Stefan, et al.
Publicado: (2017)